Walgreens Boots Alliance shareholders have approved the company’s $10 billion acquisition by private equity firm Sycamore Partners during a special meeting held July 11. Here are four more notes to ...

The transaction, expected to close in Q3 or Q4, will take the company private after nearly 100 years as a public company.

In this video interview, Ramita Tandon, chief biopharma officer at Walgreens, reflects on the company’s three-year evolution as a clinical trials partner, highlighting its pharmacy-led model and ...

This would represent the third attempted sale of Boots since 2022. WBA previously sought a £7bn sale but withdrew after ...

Shareholders of Boots ’ parent company, Walgreens Boots Alliance (WBA), have approved the company’s previously-announced ...

Walgreens Boots Alliance shareholders approved the company’s sale to private equity firm Sycamore Partners at a July 11 special meeting. Walgreens announced in March that it had entered into a $10 ...

The Johnson & Johnson spinoff that makes Tylenol and Benadryl, said Chief Executive Thibaut Mongon has departed and that the company is considering simplifying its portfolio amid a recent sales slump.

Walgreens Boots Alliance should be a private company before the end of the year after jumping the potential hurdle of a ...

The national pharmacy retailer's "footprint optimization" strategy is touching down in southeastern Wisconsin, with ...

Apple Offers as Much as $150 Million for Formula One U.S. Rights The bid puts F1 on track for a significantly more lucrative deal than it has with its current partner, Disney's ESPN. The company's ...

Shareholders of Walgreens Boots Alliance overwhelmingly approved the drugstore chain's $10 billion acquisition by private equity firm Sycamore Partners, the companies announced Friday.

Walgreens Boots Alliance (WBA) shareholders have voted in favor of the company’s acquisition by Sycamore Partners, with ...